Sabby Management, LLC Synthetic Biologics, Inc. Transaction History

Sabby Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.8 - $5.7 $215,308 - $438,307	-76,896 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.7 - $6.1 $1.65 Million - $3.72 Million	-610,408 Reduced 88.81%	76,896 $25,000
Q4 2019 Feb 14, 2020	SELL	$3.9 - $5.3 $577,804 - $785,221	-148,155 Reduced 17.73%	687,304 $348,000
Q3 2019 Nov 15, 2019	SELL	$3.9 - $5.9 $266,299 - $402,863	-68,282 Reduced 7.56%	835,459 $379,000
Q2 2019 Aug 14, 2019	BUY	$4.9 - $6.6 $1.07 Million - $1.44 Million	218,815 Added 31.95%	903,741 $497,000
Q1 2019 May 15, 2019	SELL	$5.9 - $8.1 $2.55 Million - $3.5 Million	-432,533 Reduced 38.71%	684,926 $465,000
Q4 2018 Feb 14, 2019	BUY	$5.2 - $26.8 $5.81 Million - $29.9 Million	1,117,459 New	1,117,459 $626,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.